News
Sign Up for Product Updates, Company News, and Promotional Material
Sign up for Updates, News,
and Promotional Materials
Get in touch with us
For sales enquiries
For all sales enquiries please contact the team at sales@exsurgo.com.
Media
For all media enquires please contact the team at sales@exsurgo.com with your contact details and request. Images and video of the Axon product are available here.
Filter
Tech companies to look out for in 2023
With the tech scene currently booming in New Zealand, and with more and more innovative companies coming up every week, local creative business outlet, Idealog has outlined some of the companies they …
READJanuary 13, 2023
East Kent chronic pain management medical trial launches in the UK
Exsurgo has launched new study using EEG neurofeedback as a therapy to manage neuropathic pain in the United Kingdom. Funded by Exsurgo, the new trial is being led by researchers from the East Kent Ho…
READDecember 16, 2022
When a game is more than play
How gamification can support treatment for chronic pain and other neurological conditions Whether it’s smoking, drinking, eating unhealthy food or even mindlessly scrolling through social media, peo…
READNovember 30, 2022
Exsurgo’s Mindpower Newsletter – November 2022
Hi all, We are thrilled to share that our final trialist has completed the Active Neurofeedback Treatment phase of the New Zealand Axon trial in partnership with Auckland University of Technology (AUT…
READConfessions of a health tech entrepreneur
This article first appeared in NZBusiness Magazine. Richard Little is an inventor making traction in the treatment of chronic pain and other neurological conditions without the use of pharmaceuticals….
READNovember 14, 2022
The challenges for NZ’s booming healthtech sector
Our CEO and Co-founder Richard Little recently featured in the first of a three-part series by NBR’s Fiona Rotherham on the current challenges facing New Zealand’s healthtech sector. The key chall…
READOctober 19, 2022